Kliinisen farmakologian yks.

Julkaisut 2001
Publications 2001

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Ahokoski O et al. Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men.
2 Björklund M et al. Spatial working memory improvement by an alpha-2-adrenoceptor agonist dexmedetomidine is not mediated through alpha2C-adrenoceptor.
3 Frang H et al. Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors.
4 Heikkinen T et al. Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta.
5 Holopainen I. Migreeni ja sen hoito. Tietoruutu L18.
6 Holopainen I et al. Changes in Neurofilament Protein-Immunoreactivity After Kainic Acid Treatment of Organotypic Hippocampal Slice Cultures.
7 Holopainen IE et al. Do antiepileptics Phenytoin, Carbamazepine, and Loreclezole show GABA receptor subtype selectivity in rat brain sections?
8 Holopainen IE et al. Angelniemen oireyhtymä - kehitysvammaisuuden ilmiasusta geeneihin.
9 Holopainen IE et al. Decreased Binding of (11 C) Flumazenil in Angelman Syndrome Patients with GABA A Receptor B 3 Subunit Deletions.
10 Huupponen R. Sydänglykosidit.
11 Huupponen R. Sydänlihaksen supistumisvoiman lisääminen. Tietoruutu L31.
12 Huupponen R et al. Kipulääkitys on Suomessa kovin erilaista verrattuna muihin Pohjoismaihin.
13 Huupponen R et al. Potentiaaliset lääkeinteraktiot statiinihoidon aikana.
14 Huupponen R, Rouru J. Insuliini. Tietoruutu L45.
15 Ihalainen JA et al. Alpha2C-adrenoceptors modulate the effect of methyphenidate on response rate and discrimination accuracy in an operant test.
16 Kailajärvi M et al. Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests.
17 Kallio J. Veren hyytymiseen vaikuttavat lääkeaineet.
18 Kallio J et al. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans.
19 Kallio J et al. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the Prepro-NPY.
20 Korpilahti P et al. Early and Late Mismatch Negativity Elicited by Words and Speech-Like Stimuli in Children.
21 Krause CM et al. Event-related desynchronization and synchronization during a memory task in children.
22 Laine K. Gonadotropiinit ja sukupuolihormonit ja niiden vastavaikuttajat.
23 Laine K. Sytokromi P450 -entsyymien merkitys lääkehoidossa.
24 Laine K. Tärkeimpien sytokromi P450 (CYP) -entsyymien merkitys lääkeaineiden metaboliassa ja yhteisvaikutuksissa. Tietoruutu L65.
25 Laine K et al. CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline.
26 Laine K et al. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
27 Laitio T et al. Mitä sydämen sykevaihtelu kertoo?
28 Liitti S et al. Immunoaffinity purification and reconstitution of human alfa2-adrenergic receptor subtype C2 into phosphoilipid vesicles.
29 Luukkaa V et al. Effects of estrous cycle and steroid replacement on the expression of leptin and uncoupling proteins in adipose tissue in the rat.
30 Lähteenmäki PM et al. Cognitive functions of adolescent childhood cancer survivors assessed by event-related potentials.
31 Mildh LH et al. The concentration-effect relationship of the respiratory depressant effects of alfentanil and fentanyl.
32 Nyrönen T et al. Molecular mechanism for agonist-promoted alfa2A-adrenoceptor activation by norepinephrine and epinephrine.
33 Penttilä J et al. Spontaneous baroreflex sensitivity as a dynamic measure of cardiac anticholinergic drug effect.
34 Penttilä J. et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns.
35 Penttilä J. et al. Pharmacokinetic-pharmacodynamic model for the anticholinergic effect of glycopyrrolate.
36 Penttilä J. et al. Effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.
37 Rouru J, Huupponen R. Diabeteslääkkeet.
38 Salminen E, Ahokoski O. Ensilinjan hoito hormoniherkässä rintasyövässä.
39 Scheinin H. Riittääkö otoskoko?
40 Scheinin H. Lääketutkimuksen suunnittelu ja toteutus A.D. 2001.
41 Scheinin M. Lääkeaineiden vaikutusmekanismit: reseptorit*.
42 Scheinin M. Lääkeaineiden sitoutuminen reseptoriin. Tietoruutu L2.
43 Scheinin M et al. Evaluation of the alpha2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models.
44 Snapir A et al. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events.
45 Snapir A et al. G-protein beta3 subunit C825T polymorphism: no association with risk for hypertension and obesity.
46 Vainio-Jylhä E et al. Plasma concentration of topically applied betaxolol in elderly glaucoma patients.
47 Virtanen KA et al. Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose ([18F]FDG) and PET in combination with microdialysis.
Julkaisutietokanta 7.10.2004 Publications Data Base 7.10.2004